Boston Scientific advert

59

Everolimus-Eluting Platinum Chromium Coronary Stent System

Drug-eluting stent technology with a durable polymer has shown encouraging efficacy compared with bare metal stents, significantly reducing restenosis and revascularization procedures. Still, there remains a concern with long-term durable polymer exposure.

What if there was a technology that offered the benefits of being able to improve the ability to acutely treat patients, improve the vessel’s ability to heal, and free patients from long-term polymer exposure?

Introducing the SYNERGY Stent

Designed to help patients heal from day one and beyond


LEAVE A REPLY